Evidence map›Paper›PMID 29057257›Full record

ArticleBioMed research international2017

Serological Analysis and Drug Resistance of

Dong Du, Shuping Liao, Yan Wu, Yang Jiao, Di Wu, Weiqing Wu, Dapeng Yu

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Seroepidemiological survey ofFrontiers in pediatrics · 2025
    Article
  4. ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection forFrontiers in cellular and infection microbiology · 2024
    Article
  5. Severe problem of macrolides resistance to common pathogens in China.Frontiers in cellular and infection microbiology · 2023
    Review
  6. Laboratory analysis of positive rate ofTranslational pediatrics · 2022
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dong Du *Shenzhen People's Hospital, Shenzhen, Guangdong, China.
Shuping Liao *Shenzhen People's Hospital, Shenzhen, Guangdong, China.ORCID 0000-0003-1332-965X
Yan Wu *Shenzhen People's Hospital, Shenzhen, Guangdong, China.ORCID 0000-0002-5023-2593
Yang Jiao *Shenzhen People's Hospital, Shenzhen, Guangdong, China.ORCID 0000-0002-8388-0634
Di WuShenzhen People's Hospital, Shenzhen, Guangdong, China.ORCID 0000-0003-2980-6502
Weiqing WuShenzhen People's Hospital, Shenzhen, Guangdong, China.
Dapeng YuShenzhen YHLO Biotech Co., Ltd., Shenzhen, Guangdong, China.
ShenZhen People’s Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo understand the prevalence and distribution of

methodsThis study included a total of 4500 healthy subjects who were given physical examination in Shenzhen People's Hospital from January to December in 2016. Venous blood was drawn from people to detect the MP- and CP-specific IgG and IgM in the serum using chemiluminescence immunoassay (CLIA). The relationship of MP and CP infections with patient age, seasons, and percentage of infections was analyzed.

conclusionCP and MP cause high rate of asymptomatic infection, which may be associated with the high incidence of CP and MP infection, especially in children and the elderly population. Therefore, the implementation of effective and practical prevention measures has become an urgent need. MP culture and drug sensitivity test should be performed as early as possible in patients with manifested MP infections in order to ensure timely and proper treatment and to reduce the emergence of drug-resistant strains.

Indexed as

AdolescentAdultAgedAntibodies, BacterialChildChild, PreschoolChinaChlamydophila InfectionsChlamydophila pneumoniaeDrug Resistance, BacterialFemaleHumansMaleMiddle AgedMycoplasma pneumoniaePneumonia, MycoplasmaAntibodies, Bacterial

Identifiers

PMID29057257
PMCPMC5625799
OpenAlexW2755470689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.